Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Orthocell

Tracked across 1 events · 8 articles · First seen Apr 15, 2026 · Last active Apr 16, 2026

Sentiment
75
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
4 75
Regulatory
Orthocell has secured approval for its Remplir nerve repair device to be used across the United States===United States Department of Defense and Veterans Affairs hospital networks. This significantly expands Orthocell's access to the U.S. market and is expected to drive commercialization and revenue momentum.
Apr 15, 2026 · 8 articles
90 Orthocell expanded U.S. market access United StatesOrthocell Remplir Approved...
60 Orthocell demonstrated Remplir's value in conflict-related injuries UkraineOrthocell Remplir Approved...
NEWSDESK
Track Orthocell live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.